Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.47 |
| ▸ | DRD4 | P21917 | 6/20 | 0.43 |
| ▸ | DRD2 | P14416 | 5/20 | 0.43 |
| ▸ | DRD3 | P35462 | 4/20 | 0.43 |
| ▸ | HTR2C | P28335 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25362300 | 1.00 | MEN1 (0.47) | MEN1KMT2ASIGMAR1DRD4DRD2 | |
| SCHEMBL26004216 | 0.91 | MEN1 (0.48) | MEN1KMT2ASIGMAR1DRD4DRD2 | |
| SCHEMBL26004166 | 0.90 | DRD4 (0.48) | MEN1KMT2ASIGMAR1DRD4DRD2 | |
| SCHEMBL25359715 | 0.90 | DRD4 (0.48) | MEN1KMT2ASIGMAR1DRD4DRD2 | |
| SCHEMBL25357836 | 0.90 | SIGMAR1 (0.49) | MEN1KMT2ASIGMAR1DRD4DRD2 | |
| SCHEMBL26004274 | 0.90 | SIGMAR1 (0.49) | MEN1KMT2ASIGMAR1DRD4DRD2 | |
| SCHEMBL25358228 | 0.90 | SIGMAR1 (0.54) | MEN1KMT2ASIGMAR1DRD4DRD2 | |
| SCHEMBL26004163 | 0.90 | SIGMAR1 (0.54) | MEN1KMT2ASIGMAR1DRD4DRD2 | |
| SCHEMBL30623484 | 0.89 | MEN1 (0.44) | MEN1KMT2ASIGMAR1DRD4DRD2 | |
| SCHEMBL25357242 | 0.89 | MEN1 (0.46) | MEN1KMT2ASIGMAR1DRD4DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4476207-A1 | SPIRO PIPERIDINE DERIVATIVES AS INHIBITORS OF APOL1 AND METHODS OF USING SAME | Vertex Pharmaceuticals Incorporated (US) | 2024-12-18 | — | — | EP | disclosed |
| WO-2023154314-A1 | SPIRO PIPERIDINE DERIVATIVES AS INHIBITORS OF APOL1 AND METHODS OF USING SAME | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2023-08-17 | — | — | WO | disclosed |
| WO-2023154314-A1 | SPIRO PIPERIDINE DERIVATIVES AS INHIBITORS OF APOL1 AND METHODS OF USING SAME | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2023-08-17 | — | — | WO | disclosed |